Results 1 to 10 of about 134 (126)

EPSILON-AMINOCAPROIC ACID [PDF]

open access: yesLancet, The, 1974
M D Shaw
exaly   +2 more sources

INTRAARTICULAR EPSILON AMINOCAPROIC ACID VERSUS TRANEXAMIC ACID IN TOTAL KNEE ARTHROPLASTY

open access: yesActa Ortopédica Brasileira, 2021
Objective: To examine and compare the clinical efficacy of intraarticular epsilon aminocaproic acid (EACA) and tranexamic acid (TXA) in total knee arthroplasty (TKA).
JOAO PAULO FERNANDES GUERREIRO   +5 more
doaj   +1 more source

Combination of Intravenous and Intra‐Articular Application of Tranexamic Acid and Epsilon‐Aminocaproic Acid in Primary Total Knee Arthroplasty: A Prospective Randomized Controlled Trial

open access: yesOrthopaedic Surgery, 2023
Objective There were limited randomized controlled trials (RCTs) of epsilon‐aminocaproic acid (EACA) versus tranexamic acid (TXA) in total knee arthroplasty (TKA).
Che Zheng   +6 more
doaj   +1 more source

A New Insight on the Radioprotective Potential of Epsilon-Aminocaproic Acid

open access: yesMedicina, 2020
Background and objectives: The aim of the study was to scrutinize the ability of epsilon-aminocaproic acid (EACA) to prevent radiation-induced damage to human cells.
Timur Saliev   +8 more
doaj   +1 more source

Epsilon aminocaproic acid (EACA) myopathy [PDF]

open access: yesPostgraduate Medical Journal, 1979
SummaryTwo female patients developed a severe, painful proximal myopathy after taking 18–30 g of epsilon-aminocaproic acid daily for 5 weeks. Marked elevations of serum aminotransferases, creatine kinase and aldolase levels were found and the first patient had electromyographic and muscle biopsy changes of an acute monophasic, necrotising myopathy at ...
R J, Lane   +3 more
openaire   +2 more sources

Comparison of intraoperative tranexamic acid and epsilon-aminocaproic acid in cardiopulmonary bypass patientsCentral MessagePerspective

open access: yesJTCVS Open, 2020
Objective: To compare tranexamic acid (TXA) and epsilon-aminocaproic acid (EACA) in patients undergoing cardiac surgery with cardiopulmonary bypass. Methods: Over a consecutive 2-year period, 824 adult cardiac surgery patients who received TXA during an ...
Mark Broadwin, MS   +6 more
doaj   +1 more source

The Optimal Dose, Efficacy and Safety of Tranexamic Acid and Epsilon‐Aminocaproic Acid to Reduce Bleeding in TKA: A Systematic Review and Bayesian Network Meta‐analysis

open access: yesOrthopaedic Surgery, 2023
Objective The optimal dose and efficacy of tranexamic acid (TXA) and epsilon‐aminocaproic acid (EACA) in total knee arthroplasty (TKA) were under controversial, and we aimed to make comparisons between different doses of TXA and EACA in intravenous (IV ...
Che Zheng   +7 more
doaj   +1 more source

Tranexamic versus aminocaproic acids in patients with total hip arthroplasty: a retrospective study

open access: yesBMC Musculoskeletal Disorders, 2022
Background Recently, tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) have been applied in total hip arthroplasty (THA). However, doubts in clinicians’ minds about which medicine is more efficient and economical in THA need to be clarified ...
Hui Xie   +8 more
doaj   +1 more source

Influência do ácido épsilon aminocapróico no sangramento e na hemotransfusão pós-operatória em cirurgia valvar mitral Epsilon-aminocaproic acid influence in bleeding and hemotransfusion postoperative in mitral valve surgery

open access: yesBrazilian Journal of Cardiovascular Surgery, 2010
INTRODUÇÃO: O ácido épsilon aminocapróico é um antifibrinolítico usado em cirurgia cardiovascular a fim de inibir a fibrinólise e reduzir o sangramento após circulação extracorpórea (CEC).
Ricardo Adala Benfatti   +5 more
doaj   +1 more source

Systemic allergic dermatitis to epsilon‐aminocaproic acid [PDF]

open access: yesContact Dermatitis, 2009
A 47-year-old Caucasian woman had a pruriginous dermatitis involving her axillary, infra-mammary and inguinal flexures, and the lateral aspects of her trunk. Confluent erythematous patches without epidermal detachment were observed, sparing the extremities and mucous membranes (Fig. 1). There were no systemic symptoms.
Cunha, D   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy